BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 23.5% in February

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 1,300 shares, a decrease of 23.5% from the February 13th total of 1,700 shares. Based on an average daily trading volume, of 1,200 shares, the days-to-cover ratio is currently 1.1 days.

BioSyent Price Performance

BIOYF stock opened at $7.79 on Monday. BioSyent has a one year low of $5.93 and a one year high of $8.90. The company’s 50 day moving average price is $7.70 and its two-hundred day moving average price is $7.89.

BioSyent Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, March 3rd were paid a $0.0347 dividend. This is a boost from BioSyent’s previous dividend of $0.03. This represents a yield of 1.77%. The ex-dividend date of this dividend was Friday, February 28th.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.